By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoBio Corporation 

P.O. Box 8110

Ann Arbor  Michigan  48107  U.S.A.
Phone: 734-302-4000 Fax: 734-302-6150


Start Up

Company News
NanoBio Corporation And Porton Biopharma Receive Approval To Advance Next Generation Anthrax Vaccine 6/19/2017 8:56:29 AM
NanoBio Corporation Receives SBIR Grant For Genital Herpes Vaccine 3/6/2017 8:44:32 AM
NanoBio Corporation Awarded U.S. Patent For RSV Vaccine 12/19/2016 11:52:26 AM
NanoBio Corporation To Present Intranasal Pertussis Vaccine Data At The Mucosal Immunology Course & Symposium Meeting 7/27/2016 8:19:07 AM
NanoBio Corporation's Chlamydia Vaccine Improves Clearance Of Bacteria And Prevents Pelvic Inflammatory Disease In Mice 12/2/2015 9:44:38 AM
NanoBio Corporation's Genital Herpes Vaccine Demonstrates Efficacy In Guinea Pigs As Both A Prophylactic And A Therapeutic Vaccine 9/23/2015 11:02:04 AM
NanoBio CorporationTo Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection 10/8/2014 8:52:09 AM
NanoBio Corporation's Intranasal Vaccine Demonstrates Robust Protection Against Herpes Simplex-2 Infection 4/28/2014 9:40:21 AM
Merck & Co., Inc. (MRK) Licenses NanoBio Corporation Technology 3/27/2014 9:33:37 AM
NanoBio Corporation Awarded Up to $10 Million in National Institutes of Health (NIH) Funding to Develop a Pandemic Influenza Vaccine 10/29/2013 11:26:48 AM